David Buck
Stock Analyst at B. Riley Securities
(0.18)
# 3,823
Out of 4,583 analysts
13
Total ratings
21.43%
Success rate
-27.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Buck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNOV MediciNova | Assumes: Buy | $22 | $1.69 | +1,201.78% | 2 | Mar 25, 2019 | |
| SUPN Supernus Pharmaceuticals | Maintains: Buy | $68 → $65 | $32.13 | +102.30% | 3 | Nov 12, 2018 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $219 → $190 | $111.29 | +70.73% | 4 | Nov 8, 2018 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | n/a | $8.81 | - | 1 | Aug 22, 2018 | |
| ALKS Alkermes | Initiates: Buy | $60 | $28.35 | +111.64% | 1 | Jun 6, 2018 | |
| EVOK Evoke Pharma | Reinstates: Buy | $1,440 | $4.44 | +32,332.43% | 2 | Oct 19, 2017 |
MediciNova
Mar 25, 2019
Assumes: Buy
Price Target: $22
Current: $1.69
Upside: +1,201.78%
Supernus Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: $68 → $65
Current: $32.13
Upside: +102.30%
Jazz Pharmaceuticals
Nov 8, 2018
Maintains: Buy
Price Target: $219 → $190
Current: $111.29
Upside: +70.73%
Amneal Pharmaceuticals
Aug 22, 2018
Maintains: Buy
Price Target: n/a
Current: $8.81
Upside: -
Alkermes
Jun 6, 2018
Initiates: Buy
Price Target: $60
Current: $28.35
Upside: +111.64%
Evoke Pharma
Oct 19, 2017
Reinstates: Buy
Price Target: $1,440
Current: $4.44
Upside: +32,332.43%